# EDGAR Filing Document

**Accession Number:** 0001659617
**File Stem:** 0001437749-25-019300
**Filing Date:** 2025-6
**Character Count:** 2070
**Document Hash:** b82f64098e6e57e6616907588e7b954a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-25-019300.hdr.sgml**: 20250829

**ACCESSION NUMBER**: 0001437749-25-019300

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250603

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Moleculin Biotech, Inc.
- **CENTRAL INDEX KEY:** 0001659617
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 474671997
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 5300 MEMORIAL DRIVE
- **STREET 2:** SUITE 950
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77007
- **BUSINESS PHONE:** 713-300-5160

**MAIL ADDRESS:**
- **STREET 1:** 5300 MEMORIAL DRIVE
- **STREET 2:** SUITE 950
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77007

**Roth Capital Partners, LLC**

**888 San Clemente Drive**

**Newport Beach, CA 92660**

June 3, 2025

**<u>VIA EDGAR</u>**

U.S. Securities and Exchange Commission

Division of Corporation Finance

Washington, DC 20549

---

| | |
|:---|:---|
| **Re:** | **Moleculin Biotech, Inc.** |

---

**Registration Statement on Form S-1 (Registration No. 333-287727)** <br>

**Concurrence in Acceleration Request**<br>

Ladies and Gentlemen:

Roth Capital Partners, LLC ("<u>Roth</u>"), as placement agent for the referenced offering, hereby concurs in the request by Moleculin Biotech, Inc. that the effective date of the above-referenced registration statement be accelerated to 5:00 p.m. (Eastern Time), or as soon as practicable thereafter, on Wednesday, June 4, 2025, pursuant to Rule 461 under the Securities Act. Roth affirms that it is aware of its obligations under the Securities Act in connection with this offering.

[*Signature Page Follows*]

------

---

| | |
|:---|:---|
| Very truly yours,  | Very truly yours,  |
| **ROTH CAPITAL PARTNERS, LLC** | **ROTH CAPITAL PARTNERS, LLC** |
| By:  | /s/ Louis J. Ellis |
|  | Name: Louis J. Ellis  |
|  | Title: Managing Director, Equity Capital Markets  |

---